Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer

被引:1
|
作者
Domagala-Kulawik, Joanna [1 ]
机构
[1] Med Univ Warsaw, Dept Internal Dis Pneumonol & Allergol, Warsaw, Poland
关键词
T-CELLS; IMMUNOTHERAPY; CLASSIFICATION;
D O I
10.20452/pamw.4015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:233 / 234
页数:2
相关论文
共 50 条
  • [41] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Cvek, Jakub
    Feltl, David
    Knybel, Lukas
    Otahal, Bretislav
    Skacelikova, Eva
    Binarova, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537
  • [42] Stereotactic ablative radiotherapy versus surgery in older patients with stage I lung cancer
    Park, Samina
    Kim, Hak Jae
    Park, In Kyu
    Kim, Young Tae
    Kang, Chang Hyun
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (01) : 74 - 80
  • [43] Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer
    Jinhong Jung
    Si Yeol Song
    Jong Hoon Kim
    Chang Sik Yu
    Jin Cheon Kim
    Tae Won Kim
    Seong-Yun Jeong
    Su Ssan Kim
    Eun Kyung Choi
    Radiation Oncology, 10
  • [44] Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer
    Haasbeek, Cornelis J. A.
    Lagerwaard, Frank J.
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) : 2036 - 2043
  • [45] Factors Affecting Use of Stereotactic Ablative Radiotherapy (SABR) in Patients with Inoperable Lung Cancer
    Syed, Mohshin
    Jayasekera, Geeshath
    Rushd, Farwah
    LUNG CANCER, 2025, 200
  • [46] Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
    Benzaquen, Jonathan
    Bondiau, Pierre-Yves
    Otto, Josiane
    Marquette, Charles-Hugo
    Berthet, Jean-Philippe
    Naghavi, Arash O.
    Schiappa, Renaud
    Hannoun-Levi, Jean-Michel
    Padovani, Bernard
    Doyen, Jerome
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [47] Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
    Jonathan Benzaquen
    Pierre-Yves Bondiau
    Josiane Otto
    Charles-Hugo Marquette
    Jean-Philippe Berthet
    Arash O. Naghavi
    Renaud Schiappa
    Jean-Michel Hannoun-Levi
    Bernard Padovani
    Jérôme Doyen
    Radiation Oncology, 18
  • [48] Volume Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors
    Trakul, N.
    Harris, J.
    Dieterich, S.
    Maxim, P.
    Le, Q.
    Loo, B. W.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S179 - S179
  • [49] Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
    Trakul, Nicholas
    Harris, Jeremy P.
    Le, Quynh-Thu
    Hara, Wendy Y.
    Maxim, Peter G.
    Loo, Billy W., Jr.
    Diehn, Maximilian
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1462 - 1465
  • [50] Lung stereotactic ablative radiotherapy in elderly patients: safety and efficacy
    Cavallin, C.
    Badellino, S.
    Cerrato, M.
    Caivano, D.
    Chiovatero, I.
    Vella, A.
    Di Muzio, J.
    Mantovani, C.
    Levis, M.
    Ricardi, U.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S669 - S669